The Effectiveness of Influenza Vaccine
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Influenza Virus Vaccines".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 1843
Special Issue Editors
Interests: candidiasis
Special Issues, Collections and Topics in MDPI journals
Interests: vaccines; influenza; healthcare planning; HTA; health promotion
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Influenza vaccines reduce the disease burden by lowering the risk of infection, severe illness, and complications. Their effectiveness can vary each year due to several factors, including changes in the virus, the selection of vaccine strains, age groups, and individual immune responses. Ongoing research aims to improve vaccine formulations and develop influenza vaccines that offer more robust and longer-lasting protection. Research is also critical for evidence-based decision-making in public health and is fundamental to maintaining progress and trust in immunization programs. This Special Issue will address all aspects of influenza vaccine effectiveness.
Dr. Filippo Ansaldi
Dr. Amicizia Daniela
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- effectiveness
- influenza vaccines
- infection control
- influenza vaccination
- seasonal influenza vaccines
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
